SAT-561 Effects of Mineralocorticoid Receptor Antagonists on Primary Aldosteronism Screening

Background: Mineralocorticoid receptor antagonists (MRAs) are the mainstay of medical therapy for primary aldosteronism (PA), and MRAs also benefit patients with other forms of resistant hypertension and cardiovascular disorders. MRAs impact the renin-angiotensin-aldosterone system (RAAS), raising c...

Descripción completa

Detalles Bibliográficos
Autores principales: Tezuka, Yuta, Turcu, Adina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Cardiovascular Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209325/
http://dx.doi.org/10.1210/jendso/bvaa046.248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209325/
http://dx.doi.org/10.1210/jendso/bvaa046.248

Ejemplares similares